{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:05:09Z","timestamp":1790229909185,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T00:00:00Z","timestamp":1531180800000},"content-version":"vor","delay-in-days":70,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Netherlands Organization for Scientific Research","award":["91712386"],"award-info":[{"award-number":["91712386"]}]},{"DOI":"10.13039\/501100002997","name":"Dutch Kidney Foundation","doi-asserted-by":"publisher","award":["13A3D301"],"award-info":[{"award-number":["13A3D301"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.bbadis.2018.03.003","type":"journal-article","created":{"date-parts":[[2018,3,4]],"date-time":"2018-03-04T01:26:26Z","timestamp":1520126786000},"page":"1883-1895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"PA","title":["Deletion of NLRX1 increases fatty acid metabolism and prevents diet-induced hepatic steatosis and metabolic syndrome"],"prefix":"10.1016","volume":"1864","author":[{"given":"Lotte","family":"Kors","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rampanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geurt","family":"Stokman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loes M.","family":"Butter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ntsiki M.","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nike","family":"Claessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per W.B.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coert J.","family":"Zuurbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Liebisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Girardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Florquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riekelt H.","family":"Houtkooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaklien C.","family":"Leemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2018.03.003_bb0005","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nrneph.2014.91","article-title":"Pattern recognition receptors and the inflammasome in kidney disease","volume":"10","author":"Leemans","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0010","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0015","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.it.2006.06.003","article-title":"TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity","volume":"27","author":"Creagh","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0020","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0025","first-page":"4742","article-title":"Dendritic cell activation toll-like receptor \u2013 induced changes in glycolytic metabolism regulate dendritic cell activation","volume":"115","author":"Krawczyk","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0030","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ni.2833","article-title":"TLR-driven early glycolytic reprogramming via the kinases TBK1-IKK\u025b supports the anabolic demands of dendritic cell activation","volume":"15","author":"Everts","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0035","first-page":"1","article-title":"Metabolic injury-induced NLRP3 inflammasome activation dampens phospholipid degradation","volume":"2861","author":"Rampanelli","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0040","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/ki.2013.503","article-title":"Nlrp3 is a key modulator of diet-induced nephropathy and renal cholesterol accumulation","volume":"85","author":"Bakker","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0045","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1242\/jcs.051193","article-title":"An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrix","volume":"122","author":"Arnoult","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0050","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nature06501","article-title":"NLRX1 is a regulator of mitochondrial antiviral immunity","volume":"451","author":"Moore","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0055","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2011.02.022","article-title":"NLRX1 negatively regulates TLR-induced NF-\u03baB signaling by targeting TRAF6 and IKK","volume":"34","author":"Xia","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0060","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.immuni.2011.03.026","article-title":"NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-\u03baB signaling pathways","volume":"34","author":"Allen","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0065","doi-asserted-by":"crossref","first-page":"19317","DOI":"10.1074\/jbc.M114.550111","article-title":"The mitochondrial protein NLRX1 controls the balance between extrinsic and intrinsic apoptosis","volume":"289","author":"Soares","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-014-0090-x","article-title":"Nlrx1 regulates neuronal cell death","volume":"7","author":"Imbeault","year":"2014","journal-title":"Mol. Brain"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0075","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1084\/jem.20161031","article-title":"NLRX1 dampens oxidative stress and apoptosis in tissue injury via control of mitochondrial activity","volume":"214","author":"Stokman","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0080","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3892\/ol.2012.928","article-title":"Energy metabolism of cancer: glycolysis versus oxidative phosphorylation","volume":"4","author":"Zheng","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0085","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0090","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.2337\/diacare.26.11.3153","article-title":"The metabolic syndrome as predictor of type 2 diabetes","volume":"26","author":"Lorenzo","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0095","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men","volume":"288","author":"Lakka","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0100","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nrneph.2009.114","article-title":"Impact of treating the metabolic syndrome on chronic kidney disease","volume":"5","author":"Agrawal","year":"2009","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0105","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2215\/CJN.04071206","article-title":"Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease","volume":"2","author":"Wahba","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","article-title":"Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.metabol.2017.11.003","article-title":"Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis","volume":"79","author":"Mantovani","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrneph.2017.16","article-title":"Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease","volume":"13","author":"Targher","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-121808-102132","article-title":"Nonalcoholic fatty liver disease: pathology and pathogenesis","volume":"5","author":"Tiniakos","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0135","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.dld.2017.01.147","article-title":"AISF position paper on nonalcoholic fatty liver disease (NAFLD): updates and future directions","volume":"49","author":"AISF; Italian Association for the Study of the Liver","year":"2017","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0140","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tem.2016.11.006","article-title":"Mitochondrial adaptation in nonalcoholic fatty liver disease: novel mechanisms and treatment strategies","volume":"28","author":"Sunny","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0145","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2009.11.030","article-title":"Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model","volume":"52","author":"Rector","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0150","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/1753425912467383","article-title":"NLRX1 does not inhibit MAVS-dependent antiviral signalling","volume":"19","author":"Soares","year":"2013","journal-title":"Innate Immun."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0155","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbalip.2005.12.007","article-title":"High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS\/MS)","volume":"1761","author":"Liebisch","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0165","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1194\/jlr.D005322","article-title":"A rapid and quantitative LC-MS\/MS method to profile sphingolipids","volume":"51","author":"Scherer","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0170","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nprot.2006.478","article-title":"Organelle isolation: functional mitochondria from mouse liver, muscle and cultured filroblasts","volume":"2","author":"Frezza","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0175","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0180","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1152\/ajpheart.01182.2004","article-title":"Ischemic preconditioning, insulin, and morphine all cause hexokinase redistribution","volume":"289","author":"Zuurbier","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2015.00109","article-title":"Diet impact on mitochondrial bioenergetics and dynamics","volume":"6","author":"Putti","year":"2015","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0190","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1152\/ajpgi.00182.2014","article-title":"Decreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver disease","volume":"307","author":"Galloway","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0195","doi-asserted-by":"crossref","first-page":"8713","DOI":"10.3390\/ijms15058713","article-title":"Role of mitochondria in nonalcoholic fatty liver disease","volume":"15","author":"Nassir","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0200","first-page":"1","article-title":"Laboratory protocol: citrate synthase a mitochondrial marker enzyme","volume":"4","author":"Eigentler","year":"2012","journal-title":"Mitochondrial Physiol. Netw."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0205","doi-asserted-by":"crossref","first-page":"E730","DOI":"10.1152\/ajpendo.00225.2016","article-title":"Treatment of non-alcoholic fatty liver disease (NAFLD): role of AMPK","volume":"311","author":"Smith","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0210","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1681\/ASN.2005010106","article-title":"Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults","volume":"16","author":"Kurella","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0215","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","article-title":"The metabolic syndrome and chronic kidney disease in U.S. adults","volume":"140","author":"Chen","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0220","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S2213-8587(14)70065-8","article-title":"Fatty kidney: emerging role of ectopic lipid in obesity-related","volume":"2","author":"De Vries","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0225","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/hep.28245","article-title":"Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice","volume":"63","author":"Gariani","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0230","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2016.08.024","article-title":"Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease","volume":"66","author":"Gariani","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0235","doi-asserted-by":"crossref","first-page":"15924","DOI":"10.1073\/pnas.0306981100","article-title":"Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome","volume":"100","author":"Tanaka","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0240","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nrendo.2011.138","article-title":"The role of mitochondria in insulin resistance and type 2 diabetes mellitus","volume":"8","author":"Szendroedi","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0245","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cmet.2013.05.011","article-title":"Innate immune receptors: key regulators of metabolic disease progression","volume":"17","author":"Jin","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0250","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0255","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.24341","article-title":"Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells","volume":"54","author":"Csak","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0260","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","article-title":"Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1B in mice","volume":"139","author":"Miura","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0265","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI82204","article-title":"Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver","volume":"125","author":"Satapati","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0275","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.embor.7401161","article-title":"NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production","volume":"9","author":"Tattoli","year":"2008","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep23664","article-title":"NADPH oxidase is implicated in the pathogenesis of oxidative phosphorylation dysfunction in mice fed a high-fat diet","volume":"6","author":"Garc\u00eda-Ruiz","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0285","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1242\/dmm.016766","article-title":"High-fat diet decreases activity of the oxidative phosphorylation complexes and causes nonalcoholic steatohepatitis in mice","volume":"7","author":"Garc\u00eda-Ruiz","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0290","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cphy.c130024","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0295","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0300","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrm3293","article-title":"Sirtuins as regulators of metabolism and healthspan","volume":"13","author":"Houtkooper","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0305","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cmet.2009.03.012","article-title":"AMPK: an emerging drug target for diabetes and the metabolic syndrome","volume":"9","author":"Zhang","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0310","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ncb2718","article-title":"TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop","volume":"15","author":"Settembre","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0315","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","article-title":"mTOR: from growth signal integration to cancer, diabetes and ageing","volume":"12","author":"Zoncu","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0320","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ng706","article-title":"A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure","volume":"29","author":"de Lonlay","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0325","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/hep.24031","article-title":"The GRACILE mutation introduced into Bcs1l causes postnatal complex III deficiency: a viable mouse model for mitochondrial hepatopathy","volume":"53","author":"Lev\u00e9en","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0330","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbamcr.2015.01.016","article-title":"NLRX1 acts as tumor suppressor by regulating TNF-\u03b1 induced apoptosis and metabolism in cancer cells","volume":"1853","author":"Singh","year":"2015","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0335","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.4049\/jimmunol.1601547","article-title":"NLRX1 regulates effector and metabolic functions of CD4 + T cells","volume":"198","author":"Leber","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0340","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0345","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.dld.2015.08.004","article-title":"Epidemiological modifiers of non-alcoholic fatty liver disease: focus on high-risk groups","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0350","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2337\/dc06-2247","article-title":"Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0355","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","article-title":"Macrophages, inflammation, and insulin resistance","volume":"72","author":"Olefsky","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0360","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature13478","article-title":"The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes","volume":"510","author":"Perry","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2018.03.003_bb0365","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI77812","article-title":"The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux","volume":"126","author":"Samuel","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0370","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0375","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases","volume":"27","author":"Samuel","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2018.03.003_bb0380","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of nonalcoholic fatty liver disease with insulin resistance","volume":"107","author":"Marchesini","year":"1999","journal-title":"Am. J. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918300838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918300838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T13:21:15Z","timestamp":1535030475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443918300838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0925443918300838"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.03.003","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deletion of NLRX1 increases fatty acid metabolism and prevents diet-induced hepatic steatosis and metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}